Advertisement
Week Ahead: Kicking off earnings season

Week Ahead: Kicking off earnings season

By Rachel Z. Arndt  |  October 13, 2018

UnitedHealth Group leads the pack into earnings season with its third-quarter results. In the second quarter, the company reported both higher revenue and profit.

University Hospitals posts 5% revenue bump in first half of year

University Hospitals posts 5% revenue bump in first half of year

By Lydia Coutré  |  October 01, 2018

Cleveland-based University Hospitals' finances remained strong in the first half of the year despite a high-profile crisis with its fertility clinic last spring that some industry observers believed could have led patients to go elsewhere for their care.

All about medicine Points: Hospitals re-balancing investment portfolios

All about medicine Points: Hospitals re-balancing investment portfolios

By Project Japan  |  September 29, 2018

Investment returns last year were the best since 2013 for the not-for-profit healthcare organizations participating in a survey released by the Commonfund Institute. But, the report says, reallocation of assets into more fixed-income investments may slow returns in the future.

Ascension's sur shrinks as system standardizes revenue cycle

Ascension's sur shrinks as system standardizes revenue cycle

By Tara Bannow  |  September 18, 2018

Ascension Health continues to grow its revenue, although its operating income was significantly stifled in its fiscal 2018 as the massive health system works to standardize its revenue cycle system-wide.

Summa Health begins bridging its financial gap

Summa Health begins bridging its financial gap

By Lydia Coutré  |  September 17, 2018

Following a multimillion-dollar operating loss in 2017, Summa Health in the first half of this year managed to achieve a $43 million turnaround of its finances and is back in the black.

Blood-testing startup Theranos said to be closing

Blood-testing startup Theranos said to be closing

By Associated Press  |  September 05, 2018

The once-heralded blood-testing startup Theranos is shutting down, according to a media report. Theranos was unable to sell itself and is now looking to pay unsecured creditors its remaining cash of about $5 million in the upcoming months.

Advertisement
https://viagra-on.com

look on www.rezeptfrei-viagra.com

viagraon.com
X

Subscribe and SAVE 50%